Trump Administration Says Abortion Pill Study Not Being ‘Slow-Walked’

Regulators are analyzing the safety of mifepristone, an abortion pill.

A patient prepares to take mifepristone at a clinic in Carbondale, Ill., on April 20, 2023. Evelyn Hockstein/Reuters

The Trump administration on Dec. 10 denied allegations that its study on the safety of an abortion pill has been slowed down.

Bloomberg News had reported this week, citing anonymous sources, that Food and Drug Administration Commissioner Dr. Marty Makary recently directed regulators to delay the study of mifepristone until after the 2026 midterm elections.